Conversion from once-daily Sandimmune cyclosporine to once-daily Neoral in renal transplant patients

By Arvind C.   Vathsala A.   Woo K.T.  

Transplantation Proceedings, Vol. 32, Iss. 7, 2000-11 ,pp. : 1681-1682

Elsevier

Access to resources Recommend Favorite

Pharmacokinetic study of twice vs thrice daily dosing of sandimmun neoral in pediatric renal transplant patients - A New Formulation of Ciclosporine

By Papachristou F.   Gakis D.   Sotiriou I.   Liatsis I.   Takoudas D.   Antoniadis A.  

Transplantation Proceedings, Vol. 30, Iss. 5, 1998-08 ,pp. : 1988-1990

Elsevier

Access to resources Recommend Favorite

Neoral vs Sandimmun: Interim Results of a Randomized Trial of Efficacy and Safety in Preventing Acute Rejection in New Renal Transplant Recipients

By U.K. Neoral Study Group   Lodge J.P.A.   Pollard S.G.  

Transplantation Proceedings, Vol. 29, Iss. 1, 1997-02 ,pp. : 272-273

Elsevier

Access to resources Recommend Favorite

Comparative pharmacokinetic study of neoral vs sandimmun in Japanese stable renal allograft recipients

By Takahara S.   Ohta K.   Ohashi Y.   Namii Y.   Uchida K.   Okuyama A.   Kainuma H.   Takagi H.   Takahashi K.   Morikawa H.  

Transplantation Proceedings, Vol. 31, Iss. 7, 1999-11 ,pp. : 3089-3092

Elsevier

Access to resources Recommend Favorite

Abbreviated Kinetic Profiles to Estimate Exposure to CyA in Renal Allograft Recipients Treated With Sandimmun-Neoral

By Serafinowicz A.   Gaciong Z.   Majchrzak J.   Baczkowska T.   Nowacka E.   Gradowska L.   Rowinski W.   Lao M.  

Transplantation Proceedings, Vol. 29, Iss. 1, 1997-02 ,pp. : 277-279

Elsevier

Access to resources Recommend Favorite